Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL
Abstract T-cell acute lymphoblastic leukemia (T-ALL) is a type of hematologic tumor with malignant proliferation of hematopoietic progenitor cells. However, traditional clinical treatment of T-ALL included chemotherapy and stem cell transplantation always lead to recurrence and poor prognosis, thus...
Main Authors: | Long Chen, Anqi Ren, Yuan Zhao, Hangyu Chen, Qifang Wu, Mengzhu Zheng, Zijian Zhang, Tongcun Zhang, Wu Zhong, Jian Lin, Haichuan Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-023-01513-6 |
Similar Items
-
TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets
by: Eric Genaro Salmerón-Bárcenas, et al.
Published: (2023-12-01) -
Epigenetic Regulation of Corneal Epithelial Differentiation by TET2
by: Yuzuru Sasamoto, et al.
Published: (2023-02-01) -
Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility
by: Chan-Wang Lio, et al.
Published: (2016-11-01) -
The Tet2–Upf1 complex modulates mRNA stability under stress conditions
by: Meiling Xia, et al.
Published: (2023-04-01) -
Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes
by: Yefei Shi, et al.
Published: (2023-01-01)